FDA raises concerns over Valeant's eye drop

July 22, 2016 7:36 AM

28 0

FDA raises concerns over Valeant's eye drop

Valeant Pharmaceuticals International (VRX.TO) (VRX.N) said on Friday U.S. regulators have raised concerns over a new eye drop manufactured at a Bausch + Lomb facility in Florida.

The U.S. Food and Drug Administration, in a complete response letter (CRL) regarding the eye drop for a type of glaucoma, raised concerns over Current Good Manufacturing Practice at the unit.

Also read: Apple Drops Hints About Working on Self-Driving Cars

Read more

To category page

Loading...